One-Year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan

Clinical Therapeutics

Volumn 31, Issue 6, 2009, Pages 1335-1344

  Al Abbadi, Ibrahim ^a   Qawwas, Abdelraouf ^a   Jaafreh, Mahmoud ^a   Abosamen, Taher ^a   Saket, Maisa ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

estimated cost savings; joint procurement; Jordan; pharmaceuticals; public health sector

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBIOTIC AGENT; CEPHALOSPORIN; TUBERCULOSTATIC AGENT;

ADVISORY COMMITTEE; ARTICLE; CONTROLLED STUDY; COST CONTROL; COST MINIMIZATION ANALYSIS; DRUG COST; ECONOMIC EVALUATION; FEASIBILITY STUDY; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH ECONOMICS; INTERMETHOD COMPARISON; JORDAN; PUBLIC HEALTH; PURCHASING; QUANTITATIVE ANALYSIS;

ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; COST SAVINGS; DRUG COSTS; GROUP PURCHASING; HUMANS; JORDAN; PHARMACEUTICAL PREPARATIONS; PILOT PROJECTS; PUBLIC SECTOR;

EID: 68649127351     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.05.021     Document Type: Article

References (17)

1. National Accounts of the Public Health Sector in Jordan (2006), Health Insurance Directorate, Amman, Jordan
2. Health Expenditure Annual Report, 2007 (2007), Higher Health Council of Jordan, Amman, Jordan
3. General Expenditure Review, 2006-2007 (2007), Jordan Ministry of Finance, Amman, Jordan
4. Jordan Health Sector Reform Project: Pharmaceutical Policies (2004), Health Insurance Commission, Greenway, Australia
5. Under-License Agreements for Local Pharmaceutical Manufacturers (2007), Jordan Association of Pharmaceutical Manufacturers, Amman, Jordan
6. Provisional Law No. 80 of the year 2001, Drug & Pharmacy Law. http://www.jfda.jo/EN/Laws/details.aspx?id=71 Accessed May 14, 2009
7. Provisional Law No. 30 of the year 2003. http://www.jfda.jo/EN/Laws/details.aspx?id=69 Accessed May 23, 2009
8. National Drug Policy (2002), Jordan Drug Directorate, Amman, Jordan
9. Hashemite Kingdom of Jordan Proposed Health Sector Reform Project (1997), World Bank Human Development Group in Middle East and North Africa, Amman, Jordan
10. Joint Procurement System, Provisional Law No. 91 of the year 2002. http://www.pm.gov.jo/arabic/index.php Accessed May 23, 2009
11. World Health Organization Regional Office for the Eastern Mediterranean. Jordan: Medicine prices, availability, affordability and price components. http://www.emro.who.int/dsaf/dsa786.pdf Accessed May 4, 2009
12. Alabbadi I., Crealey G., Scott M., et al. Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors. Clin Drug Investig. 26 (2006) 485-494
13. Midlöv P., Deierborg E., Holmdahl L., et al. Clinical outcomes from the use of Medication Report when elderly patients are discharged from hospital. Pharm World Sci. 30 (2008) 840-845
14. Pilote L., Abrahamowicz M., Rodrigues E., et al. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: A class effect?. Ann Intern Med. 141 (2004) 102-112
15. Wazaify M., Al-Bsoul-Younes A., Abu-Gharbieh E., and Tahaineh L. Societal perspectives on the role of community pharmacists and over-the-counter drugs in Jordan. Pharm World Sci. 30 (2008) 884-891
16. Kersnik J., and Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. J Clin Pharm Ther. 31 (2006) 577-583
17. Souza J.F., Marinho C.L., and Guilam M.C. Medicine consumption and the Internet: Critical evaluation of a virtual community [in Portuguese]. Rev Assoc Med Bras 54 (2008) 225-231